Myeloid-targeting immunotherapies overcome inhibitory barriers in immune-evasive neuroblastoma.

Ménard M, Yoda H, Nasholm N, Barata MJ, Wang L, Simonds EF, Lu ED, Wong-Michalak S, McHenry L, Farrel A, Kaufman R, Lopez V, Kennedy RJ, Fernandez GE, Shimada H, Grossmann LD, Asgharzadeh S, Maris JM, Gustafson WC, Weiss WA